The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - BMSi; Eisai; EUSA Pharma; Merck/Pfizer; Pfizer/Ipsen
A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST).
 
Marit Ahrens
No Relationships to Disclose
 
Bernard Escudier
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Oncorena; Pfizer; Roche/Genentech
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche/Genentech
Research Funding - BMS France (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche/Genentech
 
John B. A. G. Haanen
Stock and Other Ownership Interests - Neogene Therapeutics
Consulting or Advisory Role - Achilles Therapeutics (Inst); AIMM Therapeutics (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Ipsen (Inst); Molecular Partners (Inst); MSD Oncology (Inst); Neogene Therapeutics; Neon Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Third Rock Ventures (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Neon Therapeutics (Inst); Novartis (Inst)
 
Ekaterini Boleti
No Relationships to Disclose
 
Marine Gross Goupil
No Relationships to Disclose
 
Marc-Oliver Grimm
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Medac; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck Serono; MSD; Ono Pharmaceutical; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Sylvie Negrier
Honoraria - Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
Research Funding - IPSEN (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; IPSEN; Novartis; Pfizer
 
Philippe Barthelemy
Honoraria - Astellas Pharma; EUSA Pharma
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche
 
Gwenaelle Gravis
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); IPSEN (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Speakers' Bureau - Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Sanofi/Aventis (Inst)
Research Funding - BMS (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Philipp Ivanyi
Honoraria - AIMM Therapeutics; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD Oncology; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bayer/Vital; Bristol-Myers Squibb; Ipsen; Merck Serono; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Jens Bedke
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck KGaA; MSD Oncology; Novartis; Pfizer; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Ipsen; Merck KGaA; MSD Oncology; Pfizer
Research Funding - Astellas Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
 
Daniel Castellano
No Relationships to Disclose
 
Andrej Panic
No Relationships to Disclose
 
Begona Mellado
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Sanofi
Research Funding - Bayer; Janssen; Roche
Travel, Accommodations, Expenses - Janssen; Pfizer
 
Pablo Maroto-Rey
Research Funding - Roche (Inst)
 
Sylvie Rottey
No Relationships to Disclose
 
Stefanie Zschaebitz
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Merck; MSD Oncology; Pfizer; Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Merck
 
Dorothee Deckbar
No Relationships to Disclose
 
Arndt Hartmann
Honoraria - Abbvie; AstraZeneca; BMS; Boehringer Ingelheim; Ipsen; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - 3DHISTECH; AstraZeneca; Bristol-Myers Squibb; Cepheid; Diaceutics; Illumina; Ipsen; Janssen-Cilag; MSD; NanoString Technologies; Qiagen; Roche
Research Funding - AstraZeneca; BioNTech; Cepheid; Janssen-Cilag; NanoString Technologies; Roche
Expert Testimony - NanoString Technologies
 
Lothar Bergmann
No Relationships to Disclose